Mycenax Biotech Inc. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was TWD 665.341 million compared to TWD 390.844 million a year ago. Operating income was TWD 35.398 million compared to operating loss of TWD 230.254 million a year ago. Net income was TWD 30.948 million compared to net loss of TWD 218.175 million a year ago. Basic earnings per share from continuing operations was TWD 0.24 compared to basic loss per share from continuing operations of TWD 1.74 a year ago.